Corporate insider profile
Evan Lockwood Rachlin Insider Trades
Latest reported as Director of Iambic Therapeutics, Inc. (IAM).
- Purchase filings
- 1
- Reported companies
- 1
- Net open-market value
- $11,500,000
- Latest transaction
- Oct 16, 2026
Affiliated corporations
Reported company relationships
Transaction history
